Articles related to PROSTATE CANCER

In cases of prostate cancer post-aquablation therapy, managing residual tissue and persistent PSA levels poses significant challenges for surgical intervention, as detailed by Dr. Edward M. Schaeffer.

In a significant stride toward personalized medicine, researchers have utilized AI to unveil two distinct evotypes of prostate cancer, heralding a new era in the disease’s diagnosis and management. This pivotal discovery opens doors to tailored treatment strategies, potentially mitigating the adverse effects of over-treatment in prostate cancer.

Explore the potential of IS-002, an imaging agent that offers a new dimension in intraoperative prostate cancer detection, promising a more targeted approach to surgical intervention and patient management.

Understanding the complexities of neuroendocrine prostate cancer (NEPC) is crucial for advancing diagnosis and treatment. Insights into lineage plasticity and novel diagnostic tools, including PET imaging and liquid biopsies, are paving the way for more effective management strategies.

Recent studies highlight the potential of cabozantinib plus atezolizumab in improving progression-free survival for mCRPC patients and confirm the benefits of high-dose radiotherapy in high-risk prostate cancer treatment, offering new insights into personalized care strategies.

In a significant advancement, one physician’s minimally invasive technique for treating membranous urethral strictures post-radiation therapy showcases promising outcomes, including improved urethral patency and reduced operative complications, marking a pivotal shift in patient management strategies.